期刊文献+

miR-1247-5p对Smad2基因的靶向调控作用

Targets regulation of Samd2 gene expression by miR-1247-5p
下载PDF
导出
摘要 目的利用miR-1247-5p过表达模拟物mimics,研究miR-1247-5p对TGF-β信号通路中关键蛋白Smad2的靶向调控作用。方法合成模拟miR-1247-5p过表达的模拟物mimics,及抑制miR-1247-5p表达的抑制物inhibitors;同时构建与miR-1247-5p互补靶基因Smad2的3'非翻译区,将其克隆到线性化的Report荧光报告载体中。将测序鉴定阳性的report-Smad2 3'-UTR重组质粒,与miR-1247-5p的mimics/inhibitors共转染至HEK-293T细胞,通过relative luciferase activity实验验证靶向关系,并通过Western blot实验进一步检测Smad2蛋白表达水平。结果成功构建report-Smad2 3'-UTR重组质粒,Western blot实验表明转染miR-1247-5p mimics组中Smad2蛋白表达下调(P<0.05);而转染miR-1247-5p inhibitors组中,Smad2蛋白表达上调(P<0.05)。结论证实miR-1247-5p直接靶向TGF-β信号通路中关键蛋白Smad2的表达,在蛋白水平对其进行调控,为进一步研究miRNA在细胞通路中的调控作用提供了依据。 Objective By use of the miR-1247-5 p mimics which can over-express miR-1247-5 p,to explore its targeted effects on Smad2. Methods Use the commercially available miR-1247-5 p mimics and miR-1247-5 p inhibitors. Based on chemical technology to synthesize stem-loop structure RNA of Smad2 3 '-UTR which is complementary to miR-1247-5 p,and cloned it into the linearized report plasmid which was digested by restriction enzyme,then sequenced,the positive recombinants were transfected into HEK-293 T cells. Then we used the relative luciferase activity test,and Western blot test to validate the targeted regulatory relationship between miR-1247-5 p and Smad2 3 '-UTR. Results The recombinant plasmid of report-Smad2-3 ' UTR was constructed successfully,and Western blot test confirmed that the over-expression of miR-1247-5 p suppressed the expression level of Smad2 protein significantly( P〈0. 05); suppression of miR-1247-5 p expression increased the expressionlevel of Smad2 protein significantly( P〈0. 05). Conclusions miR-1247-5 p can directly target at the gene expression of Smad2. It regulates at the protein level,and lay the foundation of miRNA for further research on its signaling pathways.
出处 《基础医学与临床》 CSCD 2016年第4期445-450,共6页 Basic and Clinical Medicine
基金 国家自然科学基金(81460368) 宁夏科技支撑项目[宁科计字(2013)20号] 宁夏自然科学基金(NZ-13149)
关键词 miR-1247-5p TGF-Β信号通路 SMAD2基因 肿瘤 miR-1247-5p TGF-β signaling pathway Smad2 gene tumour
  • 相关文献

参考文献14

  • 1余东琪,周怀君.MiRNA-103的研究进展[J].基础医学与临床,2011,31(4):454-457. 被引量:2
  • 2Montanger S, Orlandi EM, Merante S,et al. The role of miR- NAs in mast ceils and other innate immune cells [ J ]. Immu- nol Rev ,2013 ,253 : 12-24.
  • 3Bierie B, Moses HL. Transforming growth factor beta ( TGF- beta) and inflammation in cancer[ J ]. Cytokine Growth Fac- tor Rev,2010,21:49-59.
  • 4周春雷.miR-155通过调控Smad2的表达抑制TGF-β的活性[J].黑龙江医学,2013,37(12):1153-1157. 被引量:1
  • 5周珏宇,石嵘,郑文岭,马文丽.microRNA与肿瘤细胞周期的关系及其研究方法进展[J].基础医学与临床,2013,33(1):9-14. 被引量:10
  • 6Cheng X, Alborzinia H, Merz KH, et al. Indirubin derivatives modulate TGFβ/BMP signaling at different levels and trig- ger ubiquitin-mediated depletion of nonactivated R-Smads [ J ]. Chem Bio1,2012,19 : 1423-1436.
  • 7Peng J, Li X, Feng Q, et al. Anti-fibrotic effect of Cordyceps sinensis polysaccharide : Inhibiting HSC activation ,TGF-β1/ Smad signalling,MMPs and TIMPs[ J]. Exp Biol Med(May- wood), 2013,238 : 668- 677.
  • 8Skeen VR,Paterson I,Paraskeva C,et al. TGF-β1 signal- ling, connecting aberrant inflammation and colorectal tumor- igenesis[ J ]. Curr Pharm Des ,2012,18:3874 - 3888.
  • 9Lynch J, Fay J, Meehan M, et al. MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multi- ple genes from the non-canonicalTGF-beta signalling path- way [ J ]. Carcinogenesis, 2012,33 : 976 - 985.
  • 10Smith AL,Iwanaga R, Drasin DJ,et al. The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and in- duces EMT and tumor initiating cell characteristics down- stream of Sixl in human breast cancer [ J ]. Oncogene, 2012,31:5162 -5171.

二级参考文献83

  • 1Peltier H J, Latham GJ. Normalization of microRNA exl6res- sion levels in quantitative RT-PCR assay: identification of suitable reference RNA targets in normal and cancerous hu- man solid tissues[ J~. RNA, 2008, 14:844 - 852.
  • 2Elbarbary RA, Takaku H, Uchiumi N, et al. Human cytosolic tRNase ZL can downregulate gene expression through miRNA[ J]. FEBS Lett, 2009, 583:3241 - 3246.
  • 3Boren T, Xiong Y, HaKam A, et al. MicroRNAs and their target messenger RNAs associated with endometrial carcino- genesis [J]. Gvnecol Oncol. 2008. 110 : 206 - 215.
  • 4Chung TK, Cheung TH, Huen NY, et al. Dysregulated mi- croRNAs and their predicted targets associated with endom- etrioid endometrial adenocarcinoma in Hong Kong women [ J ]. Int J Cancer, 2009, 124 : 1358 :- 1365.
  • 5Zhang L, Volinia S, Bonome T, et al. Genomic and epit netic alterations deregulate microRNA expression in hum1 epithelial ovarian cancer [ J ]. Proc Natl Acad Sci US1 2008, 105:7004 - 7009. |.
  • 6White NM, Chow TF, Mejia-Guerrero S, et al. Three dys- regulatea miRNAs control kallikrein 10 expression and cellproliferation in ovarian cancer [ J]. Br J Cancer, 2010, 102 : 1244 - 1253.
  • 7Emami N, Diamandis EP. Utility of kallikrein-related pep- tidases ( KLKs ) as cancer biomarkers [ J ]. C, lin Chem, 2008, 54 : 1600 - 1607.
  • 8Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor- derived exosomes as diagnostic biomarkers of ovarian cancer [ J]. Gynecol Oncol, 2008, 110 : 13 - 21.
  • 9yang GH, Wang F, Yu J, et al. MicroRNAs are involved in erythroid differentiation control[ J ]. J Cell Biochem, 2009, 107:548 - 556.
  • 10Georgantas RW, Hildreth R, Morisot S,et al. CD34 + hem- atopoietic stem-progenitor cell mieroRNA expression and function:a circuit diagram of differentiation control [ J ]. Proc Natl Acad Sei USA, 2007, 104:2750 - 2755.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部